UroGen Pharma Ltd. URGN
25.88 USD +0.56 (+2.21%)
Nov 11, 2026, 12:35 PM EST
25.40 Day range 25.94
16.50 52-week range 50.81
- YTD
- +10.50%
- 1 year
- +9.52%
Held by funds
78 US ETFs and mutual funds hold URGN · largest positions
Ownership
Held by insiders 3.48%
Held by institutions 98.35%
Float held by institutions 101.90%
Institutions 275
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| RTW Investments LP | 9.26% | 4,543,895 | 115.05M | Jun 29, 2026 |
| Blackrock Inc. | 6.53% | 3,201,461 | 81.06M | Jun 29, 2026 |
| Morgan Stanley | 5.25% | 2,576,363 | 65.23M | Jun 29, 2026 |
| Kynam Capital Management, LP | 4.96% | 2,434,207 | 61.63M | Jun 29, 2026 |
| Jefferies Financial Group Inc. | 4.48% | 2,199,652 | 55.70M | Sep 29, 2026 |
| SG Americas Securities, LLC | 4.19% | 2,052,906 | 51.98M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 2.25% | 1,103,214 | 27.93M | Sep 29, 2026 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 1.78% | 874,981 | 22.15M | Sep 29, 2026 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 0.95% | 466,099 | 11.80M | Aug 30, 2026 |
| iShares Trust-iShares Russell 2000 Growth ETF | 0.70% | 343,762 | 8.70M | Sep 29, 2026 |
| iShares Trust-iShares Biotechnology ETF | 0.66% | 323,796 | 8.20M | Sep 29, 2026 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 0.50% | 244,145 | 6.18M | Aug 30, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUTITTA CYNTHIA M | Director | Conversion of Exercise of derivative security | Nov 25, 2025 | 2,000 |
| DEGNAN CHRISTOPHER | Chief Financial Officer | Sale | Oct 7, 2025 | 2,280 |
| HOLDEN STUART M.D. | Director | Conversion of Exercise of derivative security | Nov 25, 2025 | 2,000 |
| ROBINSON JAMES A JR. | Director | Conversion of Exercise of derivative security | Aug 25, 2026 | 8,000 |
| SCHOENBERG MARK | Officer | Sale | Sep 7, 2026 | 59,882 |
| SMITH JASON DREW | General Counsel | Sale | Sep 7, 2026 | 53,141 |